Please try another search
Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company’s product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.
Name | Age | Since | Title |
---|---|---|---|
Thomas W. Samuelson | - | - | Member of Scientific Advisory Board |
Richard L. Lindstrom | 74 | - | Member of Scientific Advisory Board |
Gilbert H. Kliman | 63 | 2020 | Independent Director |
Ike K. Ahmed | - | - | Member of Scientific Advisory Board |
Kerry D. Solomon | - | - | Member of Scientific Advisory Board |
Richard A. Lewis | - | - | Member of Scientific Advisory Board |
Eric D. Donnenfeld | 66 | - | Member of Scientific Advisory Board |
Edward J. Holland | - | - | Member of Scientific Advisory Board |
Leana S. Wen | 39 | 2021 | Independent Director |
Mark J. Foley | 57 | 2014 | Lead Independent Director |
Denice M. Torres | 62 | 2021 | Independent Director |
Kuldev Singh | - | - | Member of Scientific Advisory Board |
John Berdahl | - | - | Member of Scientific Advisory Board |
Robert J. Cionni | - | - | Member of Scientific Advisory Board |
Aimee S. Weisner | 53 | 2014 | Independent Director |
Thomas William Burns | 61 | 2002 | Chairman & CEO |
Marc A. Stapley | 53 | 2014 | Independent Director |
David Frank Hoffmeister | 68 | 2014 | Independent Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review